Bone-Injected antibiotics under the microscope in knee surgery trial
NCT ID NCT07633418
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how much of the antibiotic vancomycin gets into the blood when it is given through the bone before knee replacement surgery. Thirty adults having their first knee replacement will receive the antibiotic through a needle in the bone, and blood samples will be taken during surgery to measure levels. The goal is to learn more about how this method works to prevent infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Is a patient over the age of 18 receiving treatment at UC San Diego 2. Is undergoing primary unilateral total knee arthroplasty 3. Is able to provide consent 4. Is candidate for IO administration of Vancomycin Exclusion Criteria: 1. Has had a previous surgery on the knee of interest (with the exception of arthroscopy) 2. Has a BMI \>35 3. Has a contraindication to receiving vancomycin, cefepime, or cefazolin (i.e. allergy) 4. Has diabetes with A1c \>7.5% (unless with controlled fructosamine) 5. Is immunocompromised/immunosuppressed (i.e. due to HIV, hepatitis C, end-stage renal disease, post-transplant status, chemotherapy or radiation therapy within 6 months of surgery, immunomodulating medications) 6. Has a history of active infection 7. Inability to provide consent 8. Prisoner 9. Pregnant women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Total knee arthroplasty are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UC San Diego
San Diego, California, 92093, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What do knee replacement patients really need to know? a study asks them
- Prepping the knee before surgery: a new approach to better recovery
- Which nerve drug wins the battle against Post-Surgical knee pain?
- Can a single steroid dose transform knee replacement recovery?
- Can the right anesthesia get knee replacement patients moving faster?
- Can relaxation exercises boost recovery after knee replacement?